Dana-Farber Cancer Institute (Main)

Clinical Trials

The following is a list of myeloma clinical trials at this center.

All Clinical Trials

View all active clinical trials around the US.

Marizomib Central Nervous System (CNS)
MARIZOMIB FOR MYELOMA PATIENTS WITH CNS
Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Marizomib Central Nervous System (CNS)
MARIZOMIB FOR MYELOMA PATIENTS WITH CNS
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Marizomib Central Nervous System (CNS)
MARIZOMIB FOR MYELOMA PATIENTS WITH CNS
Smoldering Myeloma

The following is a listing of clinical trials for patients with Smoldering Myeloma.

Monoclonal Gammopathy of Undetermined Significance (MGUS)

The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).

Contact This Center